100
AstraZeneca PLC is one of the world’s leading pharmaceutical groups. The turnover by source of income is distributed as follows: – product sales (94.2%). The turnover by therapeutic area is broken down between oncology (39.8%), cardiovascular, renal and metabolic diseases (24.4%), respiratory and autoimmune diseases (14.6%) and others (21.2%; inflammatory diseases, neurological diseases, gastrointestinal diseases and infectious diseases); – collaboration income (5.8%). The geographical distribution of turnover is as follows: United Kingdom (8.8%), Europe (21.6%), United States (40.3%), Americas (5.9%) and Africa-Asia-Australia (23.4%).
